CMV Viremia: Clinical Trials

3 trials for CMV Viremia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Terminated 1, Unknown 1
Phase 21Completed 1

Follow CMV Viremia: new trials by email Literature Review of CMV Viremia trials Research Report on CMV Viremia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Expansion of Virus-Specific Lymphocytes for Cell Therapy
Lymphocyte infusion (ImmuneCellVir-I) - CMV Viremia, CMV
Phase 1UnknownHospital Israelita Albert Einstein102024-06-102024-10-24
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells
CMV-specific T-cells - CMV Infection, Cytomegalovirus Infections
Phase 1TerminatedUniversity of Wisconsin, Madison32020-02-062024-10-31
Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients
Activated T-Lymphocytes - CMV Viremia, Immunosuppression-related Infectious Disease
Phase 1 / Phase 2CompletedBanc de Sang i Teixits262019-07-042024-01-24

Narrower conditions

Cytomegalovirus Infections (1)  ·  Opportunistic Infections (1)  ·  Virus Diseases (1)

Broader conditions

Infections (2)  ·  DNA Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Virus Diseases (1)

Sponsors

Banc de Sang i Teixits (1)  ·  Hospital Israelita Albert Einstein (1)  ·  University of Wisconsin, Madison (1)

Countries

Brazil (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Christain Capitini, MD (1)  ·  Jacques Galipeau, MD (1)  ·  Nelson Hamerschlak, MD, PhD (1)  ·  Pere Barba, MD, PhD (1)